Please note, The Senators (Ret.) Firm, LLP is no longer accepting Loryna claims. If you feel that you may have a potential case, we urge you to locate another law firm adequately suited to handle your claim.
Heart attacks, or more commonly referred to as myocardial infarction within the medical community, occur when part of the heart is deprived of blood for a prolonged period of time. The inadequate flow of blood deprives the heart of essential nutrients, resulting in significant damage or even death of the organ. Unfortunately certain factors may contribute to the rate in which these severe, life-threatening events happen. Women who receive Loryna treatment may significantly increase their risk of suffering from a heart attack.
If you or a loved one has suffered from a heart attack after taking Loryna, you should contact our lawyers immediately for a free confidential case evaluation. You may be entitled to compensation for your injuries and we can help.
Loryna Heart Attack Lawsuit Overview
Loryna was developed by Sandoz to the the generic compliment to the already popular oral contraceptive Yaz. Loryna received approval from the U.S. Food and drug Administration (FDA) on March 28, 2011 to be distributed as an oral contraceptive capable of preventing pregnancy. Shortly after it was approved, Loryna was launched in the United States.
As a fourth generation contraceptive, Loryna utilizes an active ingredient known as drospirenone. Drospirenone is a progestin that has the inherent ability to alter the conditions in the cervical and uterine lining, therefore preventing the ovulation process in women. By suppressing what are known as gonadotropins, drospirenone inhibits ovulation by altering the cervical mucus (which increases the difficulty of sperm entry into the uterus) and the endometrium (which reduces the likelihood of implantation).
While Loryna has helped women prevent unwanted pregnancy for approximately one year, those who took it may be unaware of the dangerous side effects associated with it. Recent data suggests that Loryna treatment may result in catastrophic complications. Accordingly, representatives from a Reproductive Health Drugs Advisory Committee and a Drug Safety and Risk Management Advisory Committee of the FDA convened to discuss the safety and efficacy of fourth generation contraceptives that contain drospirenone. During the meeting, it was acknowledged that drospirenone may elevate potassium levels too much. Subsequently, such an elevation may result in the development of severe blood clots known as deep vein thrombosis (DVT). If one of these DVTs were to develop in an artery or vein that inhibits the flow of blood through the heart, the risk of a heart attack may increase. If you have taken this contraceptive and are worried about experiencing dangerous side effects, contact one of our lawyers to see if you qualify for a Loryna heart attack lawsuit.
Heart Attack
Heart attacks are directly correlated to a distinct lack of blood flow that neglects to provide coronary tissue with the appropriate nutrients to survive. The inhibition of oxygenated blood flow through the heart, often caused by a blood clot, starves the heart of nutrients. The longer the heart is deprived of these nutrients, the more damage is sustained by the coronary tissue. If the flow of blood is blocked for too long, the heart may fail.
While heart attacks are unpredictable, there are signs and symptoms to take into consideration right before they happen. The following is a comprehensive list of possible symptoms you may feel right before a heart attack:
- Chest pain or discomfort
- Upper body pain
- Stomach pain
- Shortness of breath
- Anxiety
- Lightheadedness
- Sweating
- Nausea
- Vomiting
- Heartburn
- Clammy skin
- Unusual or unexplained fatigue
Unfortunately, once a patient has suffered from a heart attack, their chance of having a subsequent one is increased. How well they do after the heart attack depends on the damage to their heart muscle and heart valves, and where that damage has taken place. If the heart can no longer pump blood in a sufficient manner, they may experience heart failure.
FDA Safety Communication
According to an FDA Safety Communication, the agency is aware of two newly published studies that evaluated the risk of venous thromboembolism (VTE) in women who use birth control pills that contain drospirenone. The two recently published studies looked at whether there is a higher risk of blood clots in women taking birth control pills containing the progestin drospirenone when compared to similar women taking birth control pills containing a different progestin called levonorgestrel. These two new studies reported that there is a greater risk of VTE associated with birth control pills that contain drospirenone. The development of VTE may result in several severe, life-threatening complications, one of which is the development of a heart attack.
Similar Drospirenone-Containing Contraceptives
The following fourth generation contraceptives contain drospirenone and may also significantly increase the risk of a woman suffering from a severe heart attack:
Do I Have a Loryna Heart Attack Lawsuit?
The trial lawyers at The Senators (Ret.) Firm, LLP have decades of experience navigating through complex legislative and regulatory issues and litigating high stakes cases all over the nation. Our law firm focuses on the representation of plaintiffs in Loryna heart attack lawsuits. We are currently accepting new cases in all 50 states.
Again, if you or a loved one has suffered from a heart attack after taking Loryna, you should contact our lawyers immediately by clicking the link below or calling toll free 1-(949) 557-5800. You may be entitled to compensation for your injuries and we can help.